Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ZAI LAB LIMITED

(ZLAB)
  Report
Real-time Estimate Cboe BZX  -  11:02 2022-12-02 am EST
37.17 USD   +2.81%
11/30Zai Lab : to Present Interim Overall Survival Results for ZEJULA« (niraparib) from the Phase 3 NORA Study at the ESMO Virtual Plenary
PU
11/29Hopes of Easing COVID Restrictions Boost Asian Equities
MT
11/18JPMorgan Chase Lowers Price Target on Zai Lab to $79 From $96, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
CommuniquÚs de presse de la sociÚtÚ ZAI LAB LIMITED
11/30Zai Lab : to Present Interim Overall Survival Results for ZEJULA« (niraparib) from the Pha..
PU
11/09ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of..
AQ
11/09Zai Lab Announces Third Quarter 2022áFinancial Results and Corporate Updates
GL
11/08Zai Lab to Present New Oncology Research at 2022 Society for Immunotherapy of Cancer An..
GL
11/08Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
GL
11/08Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer
AQ
10/31Zai Lab Announces Participation in November Investor Conferences
GL
10/31Zai Lab Announces Participation in November Investor Conferences
GL
10/28Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K)
AQ
10/18Zai Lab to Announce Third Quarter 2022 Financial Results on November 9, 2022
GL
10/14Zai Lab Launches its first Trust Report
GL
10/14Zai Lab Launches its first Trust Report
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/28Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
AQ
09/27Zai Lab : Corporate Presentation
PU
09/27Zai Lab Ltd : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financ..
AQ
09/27Seagen and Zai Lab Announce Regional Strategic Collaboration and License Agreement for ..
GL
09/20Zai Lab to Present Analysis of the Impact of Timing for ZEJULA« (niraparib) Maintenance..
GL
09/20Zai Lab to Present Analysis of the Impact of Timing for ZEJULA« (niraparib) Maintenance..
AQ
08/26Zai Lab : Updated Statement on SEC Listing Matter
PU
08/23Zai Lab Announces Participation in September Investor Conferences
GL
08/12Zai Lab : Argenx Announces European Commission Approval of VYVGART™ (efgartigimod al..
PU
08/10Zai Lab : Corporate Presentation
PU
08/09Zai Lab : Announces Second Quarter 2022 Financial Results and Corporate Updates - Form 8-K
PU
08/09ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of..
AQ
08/09Zai Lab Announces Second Quarter 2022 Financial Results and Corporate Updates
GL
08/08Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 ..
GL
08/03Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K)
AQ
07/19Zai Lab to Announce Second Quarter 2022 Financial Results on August 9, 2022
GL
07/17Zai Lab Announces Inclusion of its Ordinary Shares in Two Stock Connect Programs
GL
07/17Zai Lab Announces Inclusion of its Ordinary Shares in Two Stock Connect Programs
AQ
07/13Zai Lab Announces Acceptance by China's NMPA of the BLA for Efgartigimod for Patients w..
GL
06/27Zai Lab Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong ..
GL
06/27Zai Lab Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong ..
AQ
06/22Zai Lab Ltd : Change in Directors or Principal Officers, Amendments to Articles of Inc. or..
AQ
06/10Zai Lab Announces Breakthrough Therapy Designations Granted for Repotrectinib in China
GL
06/10Zai Lab Announces Breakthrough Therapy Designations Granted for Repotrectinib in China
AQ
06/08Zai Lab : Corporate Presentation
PU
06/03Zai Lab and Novocure Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Field..
GL
06/01Zai Lab : Updated Statement on SEC Listing Matter
PU
06/01Zai Lab : Amendment to Current Report (Form 8-K/A)
PU
06/01ZAI LAB LTD Changes in Registrant's Certifying Accountant, Financial Statements and Ex..
AQ
05/31Zai Lab : VOLUNTARY CONVERSION TO DUAL-PRIMARY LISTING ON THE MAIN BOARD OF THE STOCK EXCH..
PU
05/31Zai Lab Ltd : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/31Zai Lab to Present New PRIME Subgroup Analysis for Niraparib in Ovarian Cancer at 2022 ..
GL
05/31Zai Lab to Present New PRIME Subgroup Analysis for Niraparib in Ovarian Cancer at 2022 ..
AQ
05/25Zai Lab : 2021 Annual Report
PU
05/24Zai Lab Announces Upcoming Presentations at June Investor Conferences
GL
05/24Zai Lab Announces Upcoming Presentations at June Investor Conferences
AQ
05/20Zai Lab Announces Change to Virtual 2022 Annual General Meeting of Shareholders to be H..
GL
05/20Zai Lab Announces Change to Virtual 2022 Annual General Meeting of Shareholders to be H..
AQ
05/10ZAI LAB LTD Management's Discussion and Analysis of Financial Condition and Results of..
AQ
05/10Zai Lab Announces First Quarter 2022áFinancial Results and Corporate Updates
GL
05/10Zai Lab Announces First Quarter 2022áFinancial Results and Corporate Updates
AQ
05/05Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART« (..
GL
05/05Zai Lab Partner argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART« (..
AQ
05/02ZAI LAB LTD Changes in Registrant's Certifying Accountant, Financial Statements and Ex..
AQ
04/28Turning Point Therapeutics and Zai Lab Announce Topline Analysis in China Subpopulation..
AQ
04/28Zai Lab and Turning Point Therapeutics Announce Topline Analysis in China Subpopulation..
GL
04/21Zai Lab : Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company's Independent R..
PU
04/21Zai Lab Ltd : Changes in Registrant's Certifying Accountant, Financial Statements and Exhi..
AQ
04/21Zai Lab Announces Engagement of KPMG LLP, a U.S. Auditor, as the Company's Independent ..
AQ
04/20Zai Lab to Announce First Quarter 2022 Financial Results on May 10, 2022
GL
04/19Zai Lab Plants a Tree for Every Employee on Earth Day 2022
AQ
04/06Zai Lab to Present New Oncology Research at 2022 AACR Annual Meeting
AQ
04/01Zai Lab Ltd : Change in Directors or Principal Officers (form 8-K)
AQ
03/28Zai Lab : Submission of Matters to a Vote of Security Holders - Form 8-K
PU
03/28Zai Lab Ltd : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
03/28Zai Lab : Statement on SEC Listing Matter
PU
03/23Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be..
AQ
03/20Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA« (Niraparib) at So..
AQ
03/15Zai Lab : Announces the Appointment of Josh Smiley as Chief Operating Officer - Form 8-K
PU
03/15Zai Lab Ltd : Change in Directors or Principal Officers, Financial Statements and Exhibits..
AQ
03/15Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
GL
03/15Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer
GL
1  2  3  4  5Next
Upcoming event on ZAI LAB LIMITED